Induced Pluripotent Stem Cell (iPSC) Therapy Market Size, Share, and Trends 2025 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Induced Pluripotent Stem Cell (iPSC) Therapy Market 

5.1. COVID-19 Landscape: Induced Pluripotent Stem Cell (iPSC) Therapy Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Induced Pluripotent Stem Cell (iPSC) Therapy Market, By Cell Type / Lineage

8.1. Induced Pluripotent Stem Cell (iPSC) Therapy Market, by Cell Type / Lineage

8.1.1. Hematopoietic Cells

8.1.1.1. Market Revenue and Forecast

8.1.2. Hepatocytes

8.1.2.1. Market Revenue and Forecast

8.1.3. Cardiomyocytes

8.1.3.1. Market Revenue and Forecast

8.1.4. Neurons

8.1.4.1. Market Revenue and Forecast

8.1.5. Endothelial Cells

8.1.5.1. Market Revenue and Forecast

8.1.6. Others

8.1.6.1. Market Revenue and Forecast

Chapter 9. Global Induced Pluripotent Stem Cell (iPSC) Therapy Market, By Application

9.1. Induced Pluripotent Stem Cell (iPSC) Therapy Market, by Application

9.1.1. Regenerative Medicine

9.1.1.1. Market Revenue and Forecast

9.1.2. Drug Development & Discovery

9.1.2.1. Market Revenue and Forecast

9.1.3. Disease Modeling

9.1.3.1. Market Revenue and Forecast

9.1.4. Toxicity Screening

9.1.4.1. Market Revenue and Forecast

9.1.5. Cell Therapy

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Induced Pluripotent Stem Cell (iPSC) Therapy Market, By Product & Services 

10.1. Induced Pluripotent Stem Cell (iPSC) Therapy Market, by Product & Services

10.1.1. iPSC-derived Cells

10.1.1.1. Market Revenue and Forecast

10.1.2. Reprogramming Kits

10.1.2.1. Market Revenue and Forecast

10.1.3. Stem Cell Banking Services

10.1.3.1. Market Revenue and Forecast

10.1.4. Culture Media & Supplements

10.1.4.1. Market Revenue and Forecast

10.1.5. Instruments & Consumables

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Induced Pluripotent Stem Cell (iPSC) Therapy Market, By End-User

11.1. Induced Pluripotent Stem Cell (iPSC) Therapy Market, by End-User

11.1.1. Pharmaceutical & Biotech Companies

11.1.1.1. Market Revenue and Forecast

11.1.2. CROs & CDMOs

11.1.2.1. Market Revenue and Forecast

11.1.3. Academic & Research Institutes

11.1.3.1. Market Revenue and Forecast

11.1.4. Analog, MEMS and Others

11.1.4.1. Market Revenue and Forecast

11.1.5. Hospitals & Clinics

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Induced Pluripotent Stem Cell (iPSC) Therapy Market, By Workflow

12.1. Induced Pluripotent Stem Cell (iPSC) Therapy Market, by Workflow

12.1.1. Reprogramming

12.1.1.1. Market Revenue and Forecast

12.1.2. Cell Culture

12.1.2.1. Market Revenue and Forecast

12.1.3. Cell Characterization / Analysis

12.1.3.1. Market Revenue and Forecast

12.1.4. Engineering

12.1.4.1. Market Revenue and Forecast

12.1.5. Others

12.1.5.1. Market Revenue and Forecast

Chapter 13. Global Induced Pluripotent Stem Cell (iPSC) Therapy Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Cell Type / Lineage

13.1.2. Market Revenue and Forecast, by Application

13.1.3. Market Revenue and Forecast, by Product & Services

13.1.4. Market Revenue and Forecast, by End-User

13.1.5. Market Revenue and Forecast, by Workflow

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Cell Type / Lineage

13.1.6.2. Market Revenue and Forecast, by Application

13.1.6.3. Market Revenue and Forecast, by Product & Services

13.1.6.4. Market Revenue and Forecast, by End-User

13.1.6.5. Market Revenue and Forecast, by Workflow  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Cell Type / Lineage

13.1.7.2. Market Revenue and Forecast, by Application

13.1.7.3. Market Revenue and Forecast, by Product & Services

13.1.7.4. Market Revenue and Forecast, by End-User

13.1.7.5. Market Revenue and Forecast, by Workflow

13.2. Europe

13.2.1. Market Revenue and Forecast, by Cell Type / Lineage

13.2.2. Market Revenue and Forecast, by Application

13.2.3. Market Revenue and Forecast, by Product & Services

13.2.4. Market Revenue and Forecast, by End-User  

13.2.5. Market Revenue and Forecast, by Workflow  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Cell Type / Lineage

13.2.6.2. Market Revenue and Forecast, by Application

13.2.6.3. Market Revenue and Forecast, by Product & Services

13.2.7. Market Revenue and Forecast, by End-User  

13.2.8. Market Revenue and Forecast, by Workflow  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Cell Type / Lineage

13.2.9.2. Market Revenue and Forecast, by Application

13.2.9.3. Market Revenue and Forecast, by Product & Services

13.2.10. Market Revenue and Forecast, by End-User

13.2.11. Market Revenue and Forecast, by Workflow

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Cell Type / Lineage

13.2.12.2. Market Revenue and Forecast, by Application

13.2.12.3. Market Revenue and Forecast, by Product & Services

13.2.12.4. Market Revenue and Forecast, by End-User

13.2.13. Market Revenue and Forecast, by Workflow

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Cell Type / Lineage

13.2.14.2. Market Revenue and Forecast, by Application

13.2.14.3. Market Revenue and Forecast, by Product & Services

13.2.14.4. Market Revenue and Forecast, by End-User

13.2.15. Market Revenue and Forecast, by Workflow

13.3. APAC

13.3.1. Market Revenue and Forecast, by Cell Type / Lineage

13.3.2. Market Revenue and Forecast, by Application

13.3.3. Market Revenue and Forecast, by Product & Services

13.3.4. Market Revenue and Forecast, by End-User

13.3.5. Market Revenue and Forecast, by Workflow

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Cell Type / Lineage

13.3.6.2. Market Revenue and Forecast, by Application

13.3.6.3. Market Revenue and Forecast, by Product & Services

13.3.6.4. Market Revenue and Forecast, by End-User

13.3.7. Market Revenue and Forecast, by Workflow

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Cell Type / Lineage

13.3.8.2. Market Revenue and Forecast, by Application

13.3.8.3. Market Revenue and Forecast, by Product & Services

13.3.8.4. Market Revenue and Forecast, by End-User

13.3.9. Market Revenue and Forecast, by Workflow

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Cell Type / Lineage

13.3.10.2. Market Revenue and Forecast, by Application

13.3.10.3. Market Revenue and Forecast, by Product & Services

13.3.10.4. Market Revenue and Forecast, by End-User

13.3.10.5. Market Revenue and Forecast, by Workflow

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Cell Type / Lineage

13.3.11.2. Market Revenue and Forecast, by Application

13.3.11.3. Market Revenue and Forecast, by Product & Services

13.3.11.4. Market Revenue and Forecast, by End-User

13.3.11.5. Market Revenue and Forecast, by Workflow

13.4. MEA

13.4.1. Market Revenue and Forecast, by Cell Type / Lineage

13.4.2. Market Revenue and Forecast, by Application

13.4.3. Market Revenue and Forecast, by Product & Services

13.4.4. Market Revenue and Forecast, by End-User

13.4.5. Market Revenue and Forecast, by Workflow

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Cell Type / Lineage

13.4.6.2. Market Revenue and Forecast, by Application

13.4.6.3. Market Revenue and Forecast, by Product & Services

13.4.6.4. Market Revenue and Forecast, by End-User

13.4.7. Market Revenue and Forecast, by Workflow

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Cell Type / Lineage

13.4.8.2. Market Revenue and Forecast, by Application

13.4.8.3. Market Revenue and Forecast, by Product & Services

13.4.8.4. Market Revenue and Forecast, by End-User

13.4.9. Market Revenue and Forecast, by Workflow

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Cell Type / Lineage

13.4.10.2. Market Revenue and Forecast, by Application

13.4.10.3. Market Revenue and Forecast, by Product & Services

13.4.10.4. Market Revenue and Forecast, by End-User

13.4.10.5. Market Revenue and Forecast, by Workflow

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Cell Type / Lineage

13.4.11.2. Market Revenue and Forecast, by Application

13.4.11.3. Market Revenue and Forecast, by Product & Services

13.4.11.4. Market Revenue and Forecast, by End-User

13.4.11.5. Market Revenue and Forecast, by Workflow

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Cell Type / Lineage

13.5.2. Market Revenue and Forecast, by Application

13.5.3. Market Revenue and Forecast, by Product & Services

13.5.4. Market Revenue and Forecast, by End-User

13.5.5. Market Revenue and Forecast, by Workflow

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Cell Type / Lineage

13.5.6.2. Market Revenue and Forecast, by Application

13.5.6.3. Market Revenue and Forecast, by Product & Services

13.5.6.4. Market Revenue and Forecast, by End-User

13.5.7. Market Revenue and Forecast, by Workflow

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Cell Type / Lineage

13.5.8.2. Market Revenue and Forecast, by Application

13.5.8.3. Market Revenue and Forecast, by Product & Services

13.5.8.4. Market Revenue and Forecast, by End-User

13.5.8.5. Market Revenue and Forecast, by Workflow

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific Inc

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Takara Bio Inc

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Stemcell Technologies

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Cellular Dynamics International

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. REPROCELL USA Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Ncardia

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. ViaCyte, Inc

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Kyoto University

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Pluricell Biotech

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Bio-Techne Corporation

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms